We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Melanoma Drugs Approved by FDA; Epilepsy Drug Limited by EU
GSK Melanoma Drugs Approved by FDA; Epilepsy Drug Limited by EU
May 31, 2013
U.K. pharma giant GlaxoSmithKline (GSK) took two steps forward and a small step back last week as the FDA approved two of its melanoma drugs, but EU regulators say they want to limit the use of an anti-seizure treatment it co-markets with Valeant Pharmaceuticals.